Yttrium-90 ibritumomab tiuxetan plus busulfan, cyclophosphamide, and etoposide (BuCyE) versus BuCyE alone as a conditioning regimen for non-Hodgkin lymphoma

BACKGROUND: Radioimmunotherapy agents have a highly significant role in autologous stem cell transplantation as they improve tolerability and increase the efficacy of the conditioning regimen. METHODS: We retrospectively analyzed the efficacy and toxicity of yttrium-90 ibritumomab tiuxetan (Zevalin)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jo, Jae-Cheol, Yoon, Dok Hyun, Kim, Shin, Park, Jung Sun, Park, Chan-Sik, Huh, Jooryung, Lee, Sang-Wook, Ryu, Jin-Sook, Suh, Cheolwon
Format: Artigo
Idioma:Inglês
Publicat: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3389060/
https://ncbi.nlm.nih.gov/pubmed/22783358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/kjh.2012.47.2.119
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars